Radius Health (RDUS) Tops Q4 EPS by 19c, Revenues Beat

Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.23), $0.19 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $62.78 million versus the consensus estimate of $59.44 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• InspireMD (NSPR) Tops Q2 EPS by 1c